Autolus Therapeutics PLC (NASDAQ:AUTL)
| 2.34 Delayed Data As of 4:00pm ET |  -0.07 / -2.90%Today’s Change | 1.60 Today|||52-Week Range 3.54 | +23.16% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Operating Activities | Net Income / Starting Line | -12.5M | -19.8M | -44.9M | -- | |
| Depreciation | 476.2K | 1.0M | 1.7M | -- | ||
| Total Other Cash Flow | 3.4M | 3.2M | 6.8M | -- | ||
| Funds From Operations | -8.6M | -15.7M | -36.4M | -- | ||
| Funds From/For Other Operating Expenses | 1.2M | 799.7K | -4.7M | -- | ||
| Net Cash Flow - Operating Activities | -9.8M | -16.5M | -31.6M | -- | ||
| Investing | Capital Expenditures | -1.8M | -2.9M | -9.1M | -- | |
| Net Cash Flow Investing | -1.8M | -2.9M | -9.6M | -- | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | -- | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | -- | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | -- | -- | |
| Net Proceeds Stock Sale | 32.1M | 128.4M | 157.4M | -- | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | -- | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | -- | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | -- | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | -- | -- | |
| Net Cash Flow - Financing | 32.1M | 128.4M | 157.4M | -- | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -2.7M | 564.3K | -5.9M | -- | |
| Net Change In Cash | 20.4M | 109.1M | 116.2M | -- | ||
